Description: ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Home Page: www.adctherapeutics.com
ADCT Technical Analysis
Biopole
Epalinges,
1066
Switzerland
Phone:
41 21 653 02 00
Officers
| Name | Title |
|---|---|
| Dr. Ameet Mallik M.B.A., M.S. | CEO & Director |
| Dr. Christopher J. Martin DPHIL, Ph.D. | Co-Founder & Non-Exec. Director |
| Ms. Jennifer Creel | Chief Financial Officer |
| Dr. Michael Mulkerrin Ph.D. | Chief Technical Operations Officer |
| Dr. Patrick van Berkel Ph.D. | Chief Scientific Officer |
| Amanda Hamilton | Investor Relations Officer |
| Ms. Susan Romanus | Chief Compliance & Quality Officer |
| Mr. Peter J. Graham Esq. | Chief Legal Officer |
| Ms. Kimberly Pope | Sr. VP & Chief People Officer |
| Dr. Joseph Camardo Ph.D. | Chief Medical Officer |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| GIC Sector: | Information Technology |
|---|---|
| GIC Group: | Technology Hardware & Equipment |
| GIC Industry: | Communications Equipment |
| GIC Sub-Industry: | Communications Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.5787 |
| Price-to-Sales TTM: | 1.6407 |
| IPO Date: | 1979-03-16 |
| Fiscal Year End: | September |
| Full Time Employees: | 312 |